Drugplain

RECOMBIVAX HB 10 ug/mL

Hepatitis B Vaccine (Recombinant) · INJECTION, SUSPENSION · Bamboo US BidCo LLC

No Recall History
Plain English

RECOMBIVAX HB is a injection, suspension containing hepatitis b vaccine (recombinant) at 10 ug/mL, taken intramuscular. Manufactured by Bamboo US BidCo LLC.

Key Facts

Brand Name
RECOMBIVAX HB
Generic Name
Hepatitis B Vaccine (Recombinant)
NDC Code (Product)
83703-086
Manufacturer
Bamboo US BidCo LLC
Strength
10 ug/mL
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR, SUBCUTANEOUS
Marketing Status
Application #
BLA101066
Marketing Start
02/26/2026

Recall History

No Recall History

Frequently Asked Questions

What is RECOMBIVAX HB used for?

RECOMBIVAX HB contains Hepatitis B Vaccine (Recombinant). It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.

Is RECOMBIVAX HB a controlled substance?

RECOMBIVAX HB is not classified as a controlled substance by the DEA.

What is the generic name for RECOMBIVAX HB?

The generic name for RECOMBIVAX HB is Hepatitis B Vaccine (Recombinant). There are 5 other brand versions of Hepatitis B Vaccine (Recombinant).

What is the NDC code for RECOMBIVAX HB 10 ug/mL?

The NDC (National Drug Code) for RECOMBIVAX HB 10 ug/mL is 83703-086, listed by Bamboo US BidCo LLC.